supported by the Bristol Centre for Functional Nanomaterials and GlaxoSmithKline.
Emerging regenerative cell therapies for alveolar bone loss have begun to explore the use of cell laden hydrogels for minimally invasive surgery to treat small and spatially complex maxilla-oral defects.However,the or...